A simple DNA “switch” helps tropical butterflies to adjust the size of their wing eyespots in response to seasonal temperatures. This sheds light on the evolution of environmental sensitivity, according to scientists.

A study has found that ants are capable of altering their nests to prevent the spread of diseases. Germ-carrying ants are even left to self-isolate themselves to protect the wider colony.

Analytik Jena has introduced an optional module for 21 CFR Part 11 compliance. With this, the qpcrsoft 6.0 software now meets the requirements of the U.S. FDA regulation for electronic records and signatures.

A global study has revealed that biological invasions don’t change ecosystems in a single, uniform way. It mentions that some impacts, most notably losses of native plant diversity caused by invasive plant species, are persistent and intensify with time, while others, such as shifts in soil carbon and nutrients, often fade as invasions age.

A team from the University of Illinois has discovered how to transform discarded food into sustainable jet fuel that meets all industry standards, offering a promising route to decarbonize air travel.

Kaust and Aramco have entered into an intellectual property license agreement for commercialization of the Hybrid Unmanned Aerial Vehicle Crawler Technology. The technology boasts of merging aerial and terrestrial robotic capabilities to support inspection, monitoring, and other advanced industrial applications. 

Researchers from the Leibniz Institute for Catalysis, Ruhr University Bochum and Evonik Oxeno have developed a novel catalyst system that enables the use of the climate gas carbon dioxide as a raw material for the chemical industry.

Shimadzu has recently launched Autograph AGS-V Series in Europe. It is a significant evolution of the AGS-X system and has a load capacity of 10 kN making it ideal for quality assurance and quality control in industries such as automotive, electronics, and polymers.

Under a MOU signed between Kaust and International Medical Center, both the parties will work together to strengthen their cooperation in scientific research related to wellness, quality of life, and population health management.

Cellibre specializes in sustainable biomanufacturing and Symrise has made a strategic equity investment in the U.S.-based biotechnology company. With this move, Symrise will gain access to proprietary, fermentation-based technology which will assist in scalable production of high-value ingredients across food, beverage, cosmetics, and nutraceutical sectors.